According to Enzo Biochem's latest financial reports the company's total debt is $7.18 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-07-31 | $6.99 M | -24.39% |
2022-07-31 | $9.25 M | -59.19% |
2021-07-31 | $22.67 M | -30.84% |
2020-07-31 | $32.79 M | 617.51% |
2019-07-31 | $4.57 M | 1194.62% |
2018-07-31 | $0.35 M | -38.39% |
2017-07-31 | $0.57 M | -76.67% |
2016-07-31 | $2.45 M | -31.51% |
2015-07-31 | $3.58 M | -3.76% |
2014-07-31 | $3.72 M | -14.72% |
2013-07-31 | $4.36 M | 1676.02% |
2012-07-31 | $0.24 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | $5.49 B | 76,463.15% | ๐บ๐ธ USA |
LabCorp LH | $5.95 B | 82,816.03% | ๐บ๐ธ USA |
RadNet RDNT | $1.49 B | 20,664.80% | ๐บ๐ธ USA |
Psychemedics PMD | $2.64 M | -63.19% | ๐บ๐ธ USA |
NeoGenomics
NEO | $0.61 B | 8,418.02% | ๐บ๐ธ USA |
Qiagen QGEN | $1.53 B | 21,234.91% | ๐ณ๐ฑ Netherlands |